-
Measuring symptoms as a critical component of drug development and evaluation in hematological diseases
Loretta A Williams, Emre Yucel, Jorge E Cortes,Charles S Cleeland
Review Article: Clinical Investigation
-
Measuring symptoms as a critical component of drug development and evaluation in hematological diseases
Loretta A Williams, Emre Yucel, Jorge E Cortes,Charles S Cleeland
Review Article: Clinical Investigation
-
Measuring symptoms as a critical component of drug development and evaluation in hematological diseases
Loretta A Williams, Emre Yucel, Jorge E Cortes,Charles S Cleeland
Review Article: Clinical Investigation
-
Measuring symptoms as a critical component of drug development and evaluation in hematological diseases
Loretta A Williams, Emre Yucel, Jorge E Cortes,Charles S Cleeland
Review Article: Clinical Investigation
-
Measuring symptoms as a critical component of drug development and evaluation in hematological diseases
Loretta A Williams, Emre Yucel, Jorge E Cortes,Charles S Cleeland
Review Article: Clinical Investigation
-
Measuring symptoms as a critical component of drug development and evaluation in hematological diseases
Loretta A Williams, Emre Yucel, Jorge E Cortes,Charles S Cleeland
Review Article: Clinical Investigation
-
Measuring symptoms as a critical component of drug development and evaluation in hematological diseases
Loretta A Williams, Emre Yucel, Jorge E Cortes,Charles S Cleeland
Review Article: Clinical Investigation
-
Measuring symptoms as a critical component of drug development and evaluation in hematological diseases
Loretta A Williams, Emre Yucel, Jorge E Cortes,Charles S Cleeland
Review Article: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research in ophthalmology: the European Vision Institute Clinical Research Network (EVICR.net)
Jose Cunha-Vaz,Ceclia Martinho
Review Article: Clinical Investigation
-
Developing an international network for clinical research in ophthalmology: the European Vision Institute Clinical Research Network (EVICR.net)
Jose Cunha-Vaz,Ceclia Martinho
Review Article: Clinical Investigation
-
Developing an international network for clinical research in ophthalmology: the European Vision Institute Clinical Research Network (EVICR.net)
Jose Cunha-Vaz,Ceclia Martinho
Review Article: Clinical Investigation
-
Developing an international network for clinical research in ophthalmology: the European Vision Institute Clinical Research Network (EVICR.net)
Jose Cunha-Vaz,Ceclia Martinho
Review Article: Clinical Investigation
-
Developing an international network for clinical research in ophthalmology: the European Vision Institute Clinical Research Network (EVICR.net)
Jose Cunha-Vaz,Ceclia Martinho
Review Article: Clinical Investigation
-
Developing an international network for clinical research in ophthalmology: the European Vision Institute Clinical Research Network (EVICR.net)
Jose Cunha-Vaz,Ceclia Martinho
Review Article: Clinical Investigation
-
Developing an international network for clinical research in ophthalmology: the European Vision Institute Clinical Research Network (EVICR.net)
Jose Cunha-Vaz,Ceclia Martinho
Review Article: Clinical Investigation
-
Developing an international network for clinical research in ophthalmology: the European Vision Institute Clinical Research Network (EVICR.net)
Jose Cunha-Vaz,Ceclia Martinho
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation